Undersøgelserne viste, at udviklingen af beskyttende niveauer af antistoffer mod difteri, stivkrampe og hepatitis B forekom hos mindst 98% af spædbørnene.
The studies showed that the production of protective levels of antibodies against diphtheria, tetanus and hepatitis B occurred in at least 98% of the infants.